1

/ Press Releases
2014.08
TWi Pharmaceuticals Receives US FDA Final Approval on Generic Megestrol Acetate 125mg/ml Oral Suspension.
2014.06
TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 in United States.
2014.06
Twi Pharmaceuticals, Inc. announces the acquisition of Hainan Visum Pharmaceutical Co., Ltd in China, starting the new chapter of international mergers and acquisitions.
2014.04
TWi Announces Settlement of Lidoderm® Patent Litigation
2014.04
TWi Announces ANDA Approval of Generic Procardia XL® Tablets 30 mg, 60 mg and 90mg in the United States
2014.02
TWi Pharmaceuticals Confirms Favorable Ruling in Generic MEGACE ES® Patent Suit
2013.10
TWi Pharmaceuticals, Inc. Comments on Dexilant® Ruling
2013.07
TWi Pharmaceuticals Receives Patent Allowance for Its Reduced Food Effect Metformin Controlled Release Formulation in United States
2013.06
TWi Biotechnology Announces Completion of Patient Enrollment in Gout Flare Prophylaxis Phase II Trial for AC-201
2013.05
TWi Pharmaceuticals Announces Tentative ANDA Approval for Guanfacine Hydrochloride Extended-Release Tablets